A comparison of seasonal influenza and novel Covid-19 vaccine intentions: A cross-sectional survey of vaccine hesitant adults in England during the 2020 pandemic.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
30 11 2022
Historique:
pubmed: 12 7 2022
medline: 2 11 2022
entrez: 11 7 2022
Statut: ppublish

Résumé

We compared intention to receive the seasonal influenza vaccine with a prospective coronavirus (COVID-19) vaccine among undecided or COVID-19 vaccine hesitant individuals to better understand the underlying differences and similarities in factors associated with vaccine intention. We delivered a cross-sectional online survey in October-November 2020. We included psychological constructs and sociodemographic variables informed by theory. We conducted pairwise comparisons and multiple linear regression models to explore associations between vaccine intention and psychological constructs. We recruited 1,660 participants, where 47.6% responded that they would likely receive the influenza vaccine, 31.0% that they would probably not accept the vaccination and 21.4% were unsure. In relation to the prospective COVID-19 vaccine, 39.0% responded that they would likely receive the vaccination, 23.7% that they would probably not accept the vaccination and 37.3% were unsure.

Identifiants

pubmed: 35816683
doi: 10.1080/21645515.2022.2085461
pmc: PMC9621000
doi:

Substances chimiques

Influenza Vaccines 0
COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2085461

Références

Postgrad Med J. 2023 Jun 15;99(1172):520-528
pubmed: 37319159
Hum Vaccin Immunother. 2021 Sep 2;17(9):2851-2862
pubmed: 33857399
Vaccines (Basel). 2020 Dec 30;9(1):
pubmed: 33396832
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
EClinicalMedicine. 2021 Aug;38:101036
pubmed: 34308302
Int J Nurs Stud. 2011 Oct;48(10):1281-9
pubmed: 21474136
Lancet Reg Health Eur. 2021 Feb;1:100012
pubmed: 33954296
Health Promot Int. 2022 Feb 17;37(1):
pubmed: 34244738
Health Commun. 2022 Jul;37(8):952-961
pubmed: 33541140
BMJ. 2021 Oct 1;375:n2411
pubmed: 34598932
Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621
pubmed: 33242386
Vaccine. 2011 Sep 2;29(38):6472-84
pubmed: 21756960
J Health Commun. 2017 Jun;22(6):506-514
pubmed: 28448208
Vaccine. 2017 Oct 27;35(45):6059-6069
pubmed: 28974409
Int J Environ Res Public Health. 2021 Oct 22;18(21):
pubmed: 34769641
Vaccines (Basel). 2021 Mar 18;9(3):
pubmed: 33803755
Vaccine. 2020 Oct 21;38(45):7049-7056
pubmed: 32980199
JMIR Public Health Surveill. 2021 Apr 14;7(4):e26734
pubmed: 33651708
Public Health. 2018 Mar;156:67-78
pubmed: 29408191
Vaccine. 2020 Sep 3;38(39):6078-6079
pubmed: 32773245
JAMA. 2020 Jul 28;324(4):335-336
pubmed: 32525519
Drugs Context. 2021 Jan 05;10:
pubmed: 33456480
Vaccines (Basel). 2021 Mar 22;9(3):
pubmed: 33810131
Int J Nurs Stud. 2021 Feb;114:103854
pubmed: 33326864
Science. 2020 Jun 12;368(6496):1163
pubmed: 32527804
Hum Vaccin Immunother. 2018 Jul 3;14(7):1599-1609
pubmed: 29617183
Hum Vaccin Immunother. 2019;15(7-8):1615-1627
pubmed: 30633623
J Epidemiol Glob Health. 2022 Mar;12(1):1-6
pubmed: 34928489
Pers Individ Dif. 2021 Apr;172:110590
pubmed: 33518869
BMC Public Health. 2021 Apr 26;21(1):804
pubmed: 33902501
J Infect. 2020 Jun;80(6):e32-e33
pubmed: 32209383
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Appl Psychol Health Well Being. 2021 May;13(2):469-484
pubmed: 33634930
Prev Med Rep. 2021 Sep;23:101417
pubmed: 34094818
Front Public Health. 2022 Feb 08;9:794673
pubmed: 35211453
PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961
pubmed: 33332359
PLoS One. 2011;6(12):e29249
pubmed: 22216224
J Natl Med Assoc. 2020 Dec;112(6):681-687
pubmed: 33276969
Hum Vaccin Immunother. 2021 Dec 2;17(12):5242-5254
pubmed: 34919492
Glob Health J. 2021 Mar;5(1):51-55
pubmed: 33585053
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
Lancet. 2020 Sep 26;396(10255):898-908
pubmed: 32919524
Br J Health Psychol. 2020 Nov;25(4):1039-1054
pubmed: 32889759
J Public Health (Oxf). 2016 Dec 02;38(4):746-753
pubmed: 28158550
BMJ Open. 2021 Jul 13;11(7):e049369
pubmed: 34257095
Soc Sci Med. 2014 Jul;112:1-11
pubmed: 24788111
Res Social Adm Pharm. 2021 Sep;17(9):1596-1605
pubmed: 33431259
Public Health. 2012 Sep;126 Suppl 1:S53-S56
pubmed: 22784583
Int J Epidemiol. 2021 Aug 30;50(4):1124-1133
pubmed: 33942104
Vaccine. 2020 Jan 16;38(3):690-698
pubmed: 31668824
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Inform Med Unlocked. 2021;27:100809
pubmed: 34869828
Asia Pac J Public Health. 2021 May;33(4):434-437
pubmed: 33955270
Vaccines (Basel). 2021 Sep 13;9(9):
pubmed: 34579253
J Med Virol. 2021 Jan;93(1):64-65
pubmed: 32497290
Vaccine. 2021 Feb 12;39(7):1148-1156
pubmed: 33461834
BMC Public Health. 2021 Sep 24;21(1):1734
pubmed: 34560879
Math Biosci. 2020 Jul;325:108378
pubmed: 32507746
Vaccine. 2020 Sep 11;38(40):6194-6198
pubmed: 32684499
Health Promot Perspect. 2021 May 19;11(2):179-185
pubmed: 34195041
J Infect. 2020 Jun;80(6):e14-e18
pubmed: 32171866
Nat Med. 2021 May;27(5):749-752
pubmed: 33972794
Public Health. 2021 May;194:245-251
pubmed: 33965796
Eur J Epidemiol. 2020 Aug;35(8):785-788
pubmed: 32808095
Isr J Health Policy Res. 2021 Aug 2;10(1):43
pubmed: 34340714
J Epidemiol Community Health. 2020 Nov;74(11):964-968
pubmed: 32535550
Br J Health Psychol. 2022 May;27(2):300-319
pubmed: 34250684
Br J Soc Psychol. 2001 Dec;40(Pt 4):471-99
pubmed: 11795063
Nature. 2021 Apr;592(7853):176-178
pubmed: 33767468
Vaccine. 2018 Oct 22;36(44):6556-6558
pubmed: 28830694
Vaccine. 2020 Mar 30;38(15):3079-3085
pubmed: 32147294
Vaccine. 2016 Feb 17;34(8):1018-24
pubmed: 26672676
Psychol Health. 2018 Jun;33(6):746-764
pubmed: 29132225
Nat Microbiol. 2022 Mar;7(3):379-385
pubmed: 35132198
Andrology. 2021 Jan;9(1):65-72
pubmed: 32681716
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
Annu Rev Public Health. 2021 Apr 1;42:175-191
pubmed: 33798403

Auteurs

Vivi Antonopoulou (V)

NIHR Policy Research Unit in Behavioural Science, Centre for Behaviour Change, Department of Clinical, Educational, and Health Psychology, University College London, London, UK.

Louis Goffe (L)

NIHR Policy Research Unit in Behavioural Science - Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

Carly J Meyer (CJ)

NIHR Policy Research Unit in Behavioural Science, Centre for Behaviour Change, Department of Clinical, Educational, and Health Psychology, University College London, London, UK.

Aikaterini Grimani (A)

NIHR Policy Research Unit in Behavioural Science - Behavioural Science Group, Warwick Business School, University of Warwick, Coventry, UK.

Fiona Graham (F)

NIHR Policy Research Unit in Behavioural Science - Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

Jan Lecouturier (J)

NIHR Policy Research Unit in Behavioural Science - Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

Mei Yee Tang (MY)

NIHR Policy Research Unit in Behavioural Science - Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

Paul Chadwick (P)

NIHR Policy Research Unit in Behavioural Science, Centre for Behaviour Change, Department of Clinical, Educational, and Health Psychology, University College London, London, UK.

Falko F Sniehotta (FF)

NIHR Policy Research Unit in Behavioural Science - Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Department of Public Health, Preventive and Social Medicine, Center for Preventive Medicine and Digital Health Baden-Wuerttemberg, Heidelberg University, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH